A Turning Point in Ovarian Cancer Prevention
Today marks a turning point in our fight against ovarian cancer. As covered in The New York Times, we are launching an important campaign centered around two messages with proven … Continued
News
Ovarian Cancer Leaders Urge Genetic Testing For Increased-Risk Individuals, and Consideration of Prophylactic Surgery for All Women
[NEW YORK, Feb. 1, 2023] — In a dramatic shift of focus in the fight against ovarian cancer, Ovarian Cancer Research Alliance (OCRA), the world’s leading ovarian cancer organization, today announced they will begin … Continued
Ovarian Cancer Screening and Symptom Awareness Consensus Statement
Finding a method of early detection for ovarian cancer has been a primary focus of research for years, and was believed to be a promising approach to stopping women, or … Continued
OCRA Awards Rosalind Franklin and Liz Tilberis Research Prizes for 2022
OCRA is pleased to award research prizes to Dr. Ursula Matulonis and Dr. Pradeep Chaluvally-Raghavan, two investigators doing groundbreaking and important work in the field of ovarian cancer research. OCRA’s … Continued
Three Ways to Support OCRA in ’23 … in 20 Minutes or Less
Many people talk about New Year’s resolutions in the month of January, which is all well and good. But sometimes these long-range goals don’t exactly stick. Why not focus on … Continued
OCRA-Funded Study Reveals Role of L1CAM in Development and Spread of HGSOC
A recent study, funded in part by OCRA, has shed new light on how the most common subtype of ovarian cancer develops and metastasizes, by identifying a key molecule that … Continued
OCRA-Funded Research Sheds Light On Ovarian Cancer Resistance to Immunotherapy
As immunotherapies have seen rising success in treating several other cancers, researchers are hard at work uncovering why immunotherapy for ovarian cancer has, so far, proven ineffective. In a study … Continued
Melica Brodeur, MD, MSc | Meet a Scientist
Dr. Melica Brodeur, of Memorial Sloan Kettering Cancer Center, is a 2022 recipient of OCRA’s Mentored Investigator Grant. With her project, “Exploiting SMARCA4 Alterations for New Therapeutics in Ovarian Cancer,” … Continued
2022 Breakthroughs in Ovarian Cancer Research and Treatment
“We are truly in the Golden Age, the Renaissance, if you will, of care for people with ovarian cancer. So much is happening.” Dr. Stephanie Blank Though there is still … Continued
The Overview | December 2022
There are many different celebrations involving light during these dark winter days. And certainly, our community is a great source of brightness — from the hope of scientific breakthroughs on … Continued
Amrita Salvi, PhD | Meet a Scientist
Dr. Amrita Salvi, of University of Illinois at Chicago, is a 2022 recipient of OCRA’s Mentored Investigator Grant. With her project, “Investigating the Mechanism of Action of PHY34 in HGSOC,” … Continued
Zelei Yang, PhD | Meet a Scientist
Dr. Zelei Yang, of Dana Farber Cancer Institute, is a 2022 recipient of OCRA’s Mentored Investigator Grant. With her project, “Re-engaging the Anti-tumor Immune Response Against Ovarian Cancer,” Dr. Yang … Continued